ARALEZ PHARMACEUTICALS INC. Net Income (Loss) Available to Common Stockholders, Basic
ARALEZ PHARMACEUTICALS INC. reported Net Income (Loss) Available to Common Stockholders, Basic of -$19.74 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-08.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2018-05-08
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was -$19.74M.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-12-31 was -$45.77M.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-09-30 was -$24.44M.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for the quarter ending 2017-06-30 was -$27.52M.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for fiscal 2017 was -$125.20M.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for fiscal 2016 was -$102.98M.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$37.78M, a 292.04% decline from fiscal 2014.
- ARALEZ PHARMACEUTICALS INC. net income (loss) available to common stockholders, basic for fiscal 2014 was $19.68M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|---|
| 2018-03-31 | -$19.74M 10-Q · filed 2018-05-08 | -$65.51M derived: sum of 2 quarters · filed 2018-05-08 | -$89.95M derived: sum of 3 quarters · filed 2018-05-08 | -$117.47M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-12-31 | -$45.77M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$70.21M derived: sum of 2 quarters · filed 2018-03-14 | -$97.73M derived: sum of 3 quarters · filed 2018-03-14 | -$125.20M 10-K · filed 2018-03-14 | |
| 2017-09-30 | -$24.44M 10-Q · filed 2017-11-09 | -$51.96M derived: sum of 2 quarters · filed 2017-11-09 | -$79.44M 10-Q · filed 2017-11-09 | -$110.55M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-06-30 | -$27.52M 10-Q · filed 2017-08-09 | -$55.00M 10-Q · filed 2017-08-09 | -$86.11M derived: sum of 3 quarters · filed 2018-05-08 | -$106.71M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2017-03-31 | -$27.48M 10-Q · filed 2018-05-08 | -$58.59M derived: sum of 2 quarters · filed 2018-05-08 | -$79.19M derived: sum of 3 quarters · filed 2018-05-08 | -$96.67M derived: sum of 4 quarters · filed 2018-05-08 | |
| 2016-12-31 | -$31.12M 10-K · filed 2017-03-13 | -$51.72M derived: sum of 2 quarters · filed 2017-11-09 | -$69.19M derived: sum of 3 quarters · filed 2017-11-09 | -$102.98M 10-K · filed 2018-03-14 | |
| 2016-09-30 | -$20.60M 10-Q · filed 2017-11-09 | -$38.07M derived: sum of 2 quarters · filed 2017-11-09 | -$71.86M 10-Q · filed 2017-11-09 | -$85.19M derived: sum of 4 quarters · filed 2017-11-09 | |
| 2016-06-30 | -$17.48M 10-Q · filed 2017-08-09 | -$51.26M 10-Q · filed 2017-08-09 | -$64.59M derived: sum of 3 quarters · filed 2017-08-09 | -$72.74M derived: sum of 4 quarters · filed 2017-08-09 | |
| 2016-03-31 | -$33.79M 10-Q · filed 2017-05-09 | -$47.12M derived: sum of 2 quarters · filed 2017-05-09 | -$55.26M derived: sum of 3 quarters · filed 2017-05-09 | -$71.54M derived: sum of 4 quarters · filed 2017-05-09 | |
| 2015-12-31 | -$13.33M 10-K · filed 2017-03-13 | -$21.48M derived: sum of 2 quarters · filed 2017-03-13 | -$37.76M derived: sum of 3 quarters · filed 2017-03-13 | -$37.78M 10-K · filed 2018-03-14 | |
| 2015-09-30 | -$8.15M 10-K · filed 2017-03-13 | -$24.43M derived: sum of 2 quarters · filed 2017-03-13 | -$24.46M 10-Q · filed 2016-11-08 | ||
| 2015-06-30 | -$16.28M 10-K · filed 2017-03-13 | -$16.31M 10-Q · filed 2016-08-09 | |||
| 2015-03-31 | -$27.00K 10-K · filed 2017-03-13 | -$28.00K 10-Q · filed 2016-05-10 | |||
| 2014-12-31 | $19.68M 10-K · filed 2017-03-13 |